YHLO showcased at 13th International Congress on Autoimmunity
Summary:From 10-13 June 2022, YHLO was grandly showcased at the 13th International Congress on Autoimmunity in Athens, Greece
From 10-13 June 2022, YHLO was grandly showcased at the 13th International Congress on Autoimmunity in Athens, Greece, which is one of the largest congresses in the field of autoimmunity. As the leading brand that provides autoimmune disease diagnosis solutions in China, YHLO presents the latest chemiluminescence immunoassay (CLIA) analyzer iFlash 1200 and the bench-top analyzer iFlash 1800 during the congress. Here, YHLO met many experts and clients in the field of autoimmunity, presenting our mature diagnostic products and professionalism.
The International Congress on Autoimmunity is the largest multidisciplinary congress that discusses all aspects of the related diseases under one roof, offering courses and lectures by some of the world’s most distinguished experts.
Meanwhile, YHLO held the European Partner Meeting here in Athens, inviting our partners and friends from more than 10 countries. YHLO has made in-depth discussions on important topics of market dynamics, business strategies, and future directions. Our European partners also shared their experiences, gains and challenges. YHLO greatly appreciates all partners’ efforts and will keep providing professional products and improving market service.
YHLO is one of the few manufacturers in the industry that can provide unique tests for autoimmunity, developed more than 40 CLIA products for autoimmune diseases such as autoimmune diabetes, antiphospholipid syndrome, rheumatoid arthritis, etc. YHLO has also achieved fruitful academic achievements in areas such as SARS-Cov-2, self-immunization, reproductive health, and diabetes. YHLO will always keep on building a benchmark brand in the IVD industry with our constantly-improving service and products.